Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Filing tables
Filing exhibits
- 10-K Annual report
- 3.1 Articles of Association of Biondvax Pharmaceuticals LTD
- 4.1 Description of Securities
- 10.8 Addendum to Employment Agreement Dated May 28, 2015, Between Biondvax Pharmaceuticals LTD. and DR. Tamar-ben Yedidia
- 10.9 Addendum to Employment Agreement Dated April 1, 2012, Between Biondvax Pharmaceuticals LTD. and DR. Tamar-ben Yedidia
- 10.10 Employment Agreement Dated September 5, 2018, Between Biondvax Pharmaceuticals LTD. and Elad Mark
- 10.21 Amendment Agreement Dated August 9, 2022, to Finance Contract Dated June 19, 2017 and As Amended from Time to Time, by and Between Biondvax Pharmaceuticals LTD. and the European Investment Bank
- 14.1 Code of Conduct
- 23.1 Consent of Kost Forer Gabbay & Kasierer, Certified Public Accountant (Isr.), a Member of Ernst & Young Global, Independent Registered Public Accounting Firm for the Registrant
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
- Download Excel data file
- View Excel data file
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-239344) pertaining to the 2005 Israeli Share Option Plan and the 2018 Israeli Share Option Plan of Biondvax Pharmaceuticals Ltd. of our report dated April 17, 2023, with respect to the financial statements of Biondvax Pharmaceuticals Ltd. included in this Annual Report (Form 10-K) for the year ended December 31, 2022.
/s/ Kost Forer Gabbay & Kasierer
Kost Forer Gabbay & Kasierer
A member firm of Ernst & Young Global
Tel Aviv, Israel
April 17, 2023